HMG-CoA reductase inhibitors do not attenuate the inflammatory response associated with glutaraldehyde-fixed bioprosthetic heart valve conduits
Evidence suggests that there is an immunological response of the recipient to xenograft bioprosthetic heart valves. Information on the impact of HMG-CoA reductase inhibitors (statins) and their anti-inflammatory properties on bioprosthetic valve failure remains limited. We sought to examine the effi...
Main Author: | |
---|---|
Other Authors: | |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/1993/14909 |